Cytomatrix to create $100m US-based stem cell operation – The Australian
The Australian |
Cytomatrix to create $100m US-based stem cell operation
The Australian An Australian stem cell company has pulled off one of the country's biggest research licensing deals, turning a $21 million local operation into a newly created US-based $100m outfit to progress “game-changing” treatment for cancer patients using … |
